Astellas facing generics to big-selling Lexiscan product in US Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat Share X Astellas facing generics to big-selling Lexiscan product in US https://pharmaphorum.com/news/astellas-facing-generics-to-big-selling-lexiscan-product-in-us/
Revamped Novartis highlights top R&D programmes at management update With a reorganisation of Novartis now nearing completion, the Swiss pharma group is laying out its plans for Share X Revamped Novartis highlights top R&D programmes at management update https://pharmaphorum.com/news/revamped-novartis-highlights-top-rd-programmes-at-management-update/
AstraZeneca’s Tezspire for severe asthma gets green light in EU The European Commission has followed the lead of the US FDA and approved AstraZeneca’s Tezspire as an add-on Share X AstraZeneca’s Tezspire for severe asthma gets green light in EU https://pharmaphorum.com/news/astrazenecas-tezspire-for-severe-asthma-gets-green-light-in-eu/
Deep Dive: Communications & Commercialisation 2022 There is little doubt that the arrival of COVID-19 changed the game for communication and commercialisation efforts for Share X Deep Dive: Communications & Commercialisation 2022 https://pharmaphorum.com/sales-marketing/deep-dive-communications-commercialisation-2022/
Pharma’s New Frontier MSLs are in prime position to build new structures of engagement as the pharma industry recalibrates after the Share X Pharma’s New Frontier https://pharmaphorum.com/sales-marketing/pharmas-new-frontier/
The one sure way to escape bullying Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life Share X The one sure way to escape bullying https://pharmaphorum.com/sales-marketing/the-one-sure-way-to-escape-bullying/
How to optimise pharma’s digital HCP engagement Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if Share X How to optimise pharma’s digital HCP engagement https://pharmaphorum.com/debates-insight-sales-marketing/how-to-optimise-pharmas-digital-hcp-engagement/
Ensuring delivery of healthcare professional education Pharma companies always need to know they can get the right information to the right people at the Share X Ensuring delivery of healthcare professional education https://pharmaphorum.com/debates-insight-sales-marketing/ensuring-delivery-of-healthcare-professional-education/
Good data supports pharma sales reps to drive lead generation Allow pharma sales reps to focus on the job in hand by making sure they have access to Share X Good data supports pharma sales reps to drive lead generation https://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/
4th Gene Therapy Analytical Development Summit 2022 The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the Share X 4th Gene Therapy Analytical Development Summit 2022 https://pharmaphorum.com/events/4th-gene-therapy-analytical-development-summit-2022/
KOL Identification Without KOL Mapping Among the infinite symposia, webinars, and white papers on this topic, “KOL identification” and “KOL mapping” can find themselves Share X KOL Identification Without KOL Mapping https://pharmaphorum.com/partner-content/kol-identification-without-kol-mapping/
Meet Fishawack Health’s new CTO Geoff Thorne The experienced executive will expand our cross-functional omnichannel, data and analytics, and technology offerings, developing effective solutions to Share X Meet Fishawack Health’s new CTO Geoff Thorne https://pharmaphorum.com/partner-content/meet-fishawack-healths-new-cto-geoff-thorne/
